Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NADPH oxidase 2 (NOX2) cytochrome b558 complex is a multi-subunit enzyme system primarily responsible for the production of reactive oxygen species (ROS) during the respiratory burst in phagocytes (UniProt P04839). The complex consists of the membrane-bound cytochrome b558—a heterodimer of gp91phox and p22phox—and several cytosolic regulatory subunits, including p47phox, p67phox, and p40phox (UniProt P13498, P14598). A critical step in the activation of NOX2 is the translocation of p47phox to the membrane, where its tandem SH3 domains bind to the proline-rich region (PRR) of p22phox (PMID: 15689570). This protein-protein interaction (PPI) serves as a molecular switch that facilitates the assembly of the active enzyme complex. Dysregulation or overactivation of this interface is linked to oxidative stress-mediated damage in cardiovascular and neurodegenerative diseases (PMID: 29153444). Consequently, the p22phox–p47phox interface is a high-priority therapeutic target for small-molecule inhibitors, such as Phox-I, designed to block ROS production by disrupting this specific assembly step (PMID: 25100793).
Disruption of the protein-protein interaction between the p47phox SH3 domains and the p22phox proline-rich region, preventing the assembly and activation of the NADPH oxidase 2 complex (PMID: 25100793).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADPH oxidase 2 cytochrome b558 complex (p22phox–p47phox interface) (NOX2 (p22phox–p47phox)).